Inventor · disambiguated record
Wendy M. Blanda
Also filed as: BLANDA WENDY · BLANDA WENDY M
31 granted patents·39 pending applications·479 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
70 records- 0198US8512738B2Biodegradable intravitreal tyrosine kinase implantsEDELMAN JEFFREY L·Filed 2005·Granted Aug 20, 2013·89 cites·6 claims
- 0297US8147865B2Steroid-containing sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2006·Granted Apr 3, 2012·44 cites·15 claims
- 0397US8034370B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2007·Granted Oct 11, 2011·32 cites·8 claims
- 0497US8034366B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2007·Granted Oct 11, 2011·32 cites·9 claims
- 0596US9622957B2Dermal fillerALLERGAN INC·Filed 2015·Granted Apr 18, 2017·11 cites·9 claims
- 0696US8821870B2Method for treating atrophic age related macular degenerationROBINSON MICHAEL R·Filed 2008·Granted Sep 2, 2014·38 cites·4 claims
- 0796US8318070B2Ocular implant made by a double extrusion processSHIAH JANE-GUO·Filed 2011·Granted Nov 27, 2012·39 cites·5 claims
- 0894US10702539B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2018·Granted Jul 7, 2020·3 cites·19 claims
- 0994US9327059B2Steroid-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2014·Granted May 3, 2016·8 cites·14 claims
- 1094US9161970B2Dermal fillerTEZEL AHMET·Filed 2007·Granted Oct 20, 2015·15 cites·20 claims
- 1194US9050336B2Botulinum toxin formulationBLANDA WENDY M·Filed 2012·Granted Jun 9, 2015·34 cites·7 claims
- 1293US9192511B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2013·Granted Nov 24, 2015·10 cites·11 claims
- 1393US9044477B2Botulinum toxin formulationBLANDA WENDY M·Filed 2007·Granted Jun 2, 2015·30 cites·12 claims
- 1493US8048445B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2008·Granted Nov 1, 2011·14 cites·8 claims
- 1592US10076526B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2015·Granted Sep 18, 2018·6 cites·8 claims
- 1692US9233070B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2013·Granted Jan 12, 2016·6 cites·5 claims
- 1791US8506987B2Ocular implant made by a double extrusion processSHIAH JANE-GUO·Filed 2011·Granted Aug 13, 2013·12 cites·13 claims
- 1891US8257730B2Steroid-containing sustained release intraocular implants and related methodsHUANG GLENN T·Filed 2005·Granted Sep 4, 2012·12 cites·11 claims
- 1989US8969415B2Intraocular drug delivery systemsROBINSON MICHAEL R·Filed 2006·Granted Mar 3, 2015·15 cites·2 claims
- 2089US8771722B2Methods of treating ocular disease using steroid-containing sustained release intraocular implantsHUANG GLENN T·Filed 2012·Granted Jul 8, 2014·8 cites·10 claims
- 2188US2024238312A1Ocular implant made by a double extrusion processALLERGAN INC·Filed 2024·Application pending·0 cites
- 2287US10076492B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2016·Granted Sep 18, 2018·4 cites·4 claims
- 2385US10881608B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2018·Granted Jan 5, 2021·1 cites·7 claims
- 2483US8785394B2Sustained action formulation of cyclosporin form 2ALLERGAN INC·Filed 2012·Granted Jul 22, 2014·5 cites·2 claims
- 2582US12029683B2Ocular implant and delivery systemALCON INC·Filed 2019·Granted Jul 9, 2024·2 cites·7 claims
- 2682US2023165945A1Dermal fillerALLERGAN INC·Filed 2022·Application pending·0 cites
- 2782US2024285673A1Eye drop formulation with enhanced properties by combining sodium hyaluronate with carboxymethylcelluloseALLERGAN INC·Filed 2024·Application pending·0 cites
- 2881US10363214B2Method for treating atrophic age related macular degenerationALLERGAN INC·Filed 2014·Granted Jul 30, 2019·3 cites·14 claims
- 2981US8529927B2Alpha-2 agonist polymeric drug delivery systemsCHANG JAMES N·Filed 2006·Granted Sep 10, 2013·1 cites·4 claims
- 3081US7749530B2Kinase inhibitorsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·5 cites·31 claims
- 3181US2023172948A1Ocular implant made by a double extrusion procesALLERGAN INC·Filed 2022·Application pending·0 cites
- 3277US2022370573A1Dermal fillerALLERGAN INC·Filed 2021·Application pending·0 cites
- 3376US2021113592A1Ocular implant made by a double extrusion procesALLERGAN INC·Filed 2020·Application pending·0 cites
- 3475US2008193503A1Memantine intravitreal implantsALLERGAN INC·Filed 2008·Application pending·0 cites
- 3574US2008145407A1Methods for reducing neovascularization or edemaALLERGAN INC·Filed 2007·Application pending·0 cites
- 3673US2021121397A1Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2021·Application pending·0 cites
- 3772US2022096531A1Eye drop formulation with enhanced properties by combining sodium hyaluronate with carboxymethylcelluloseALLERGAN INC·Filed 2021·Application pending·0 cites
- 3872US2010204325A1Valproic acid drug delivery systems and intraocular therapeutic uses thereofALLERGAN INC·Filed 2009·Application pending·0 cites
- 3970US2009148527A1Intraocular formulationROBINSON MICHAEL R·Filed 2007·Application pending·0 cites
- 4068US10792345B2Dermal fillerALLERGAN INC·Filed 2017·Granted Oct 6, 2020·0 cites·11 claims
- 4168US2015147406A1Intraocular FormulationALLERGAN INC·Filed 2014·Application pending·0 cites
- 4267US8778381B2Ocular implant made by a double extrusion processALLERGAN INC·Filed 2013·Granted Jul 15, 2014·0 cites·5 claims
- 4367US2010074957A1Intraocular formulationALLERGAN INC·Filed 2009·Application pending·0 cites
- 4466US2008193502A1Memantine intravitreal implantsALLERGAN INC·Filed 2008·Application pending·0 cites
- 4565US2021236590A1Sustained action formulation of cyclosporin form 2ALLERGAN INC·Filed 2020·Application pending·0 cites
- 4665US2016243032A1Steroid-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2016·Application pending·0 cites
- 4763US2025319031A1Methods of treatment of ocular conditions with a sustained drug delivery implantALLERGAN INC·Filed 2025·Application pending·0 cites
- 4863US2013237602A1Valproic acid drug delivery systems and intraocular therapeutic uses thereofALLERGAN INC·Filed 2013·Application pending·0 cites
- 4960US2019336441A1Method for treating atrophic age related macular degenerationALLERGAN INC·Filed 2019·Application pending·0 cites
- 5060US2014038972A1Alpha-2 agonist polymeric drug delivery systemsALLERGAN INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →